Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,367 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pulmonary function and chest CT abnormalities 3 months after discharge from COVID-19, 2020-2021: A nation-wide multicenter prospective cohort study from the Japanese respiratory society.
Kamata H, Takamatsu K, Fukunaga K, Chubachi S, Nakagawara K, Namkoong H, Terai H, Tanaka K, Sato S, Hagiwara E, Takei R, Kondoh Y, Takazono T, Hashimoto M, Tasaka S, Ohrui T, Tanino Y, Mineshita M, Komase Y, Miyazaki K, Nishikawa M, Ando A, Kita H, Ichihara E, Ohshimo S, Murata Y, Ishida M, Kobayashi S, Uchida T, Tateno H, Ikari J, Terashima T, Kozu Y, Tateishi T, Shinkai M, Sagara H, To Y, Ito Y, Yamamoto M, Yamamoto Y, Kita T, Ito Y, Tomii K, Fujita Y, Funaki Y, Yatera K, Yamasue M, Komiya K, Kozawa S, Manabe H, Hozumi H, Horiguchi T, Kitajima T, Nakano Y, Nagaoka T, Hojo M, Ebihara A, Kobayashi M, Takayama K, Jinta T, Sawai T, Fukuda Y, Kaneko T, Chin K, Ogura T, Mukae H, Ishii M, Yokoyama A. Kamata H, et al. Among authors: fukunaga k. Respir Investig. 2024 Apr 25;62(4):572-579. doi: 10.1016/j.resinv.2024.02.009. Online ahead of print. Respir Investig. 2024. PMID: 38669898
The real-time reverse transcription-polymerase chain reaction threshold cycle values for severe acute respiratory syndrome coronavirus 2 predict the prognosis of coronavirus disease 2019 pneumonia.
Fukushima T, Kabata H, Yamamoto R, Suhara T, Uwamino Y, Kondo Y, Masaki K, Kamata H, Nagata H, Homma K, Kaneko Y, Ishii M, Sasaki J, Morisaki H, Hasegawa N, Fukunaga K; Keio Donner Project Team. Fukushima T, et al. Among authors: fukunaga k. Respir Investig. 2021 May;59(3):360-363. doi: 10.1016/j.resinv.2020.12.011. Epub 2021 Jan 28. Respir Investig. 2021. PMID: 33582075 Free PMC article.
Impact of upper and lower respiratory symptoms on COVID-19 outcomes: a multicenter retrospective cohort study.
Nakagawara K, Chubachi S, Namkoong H, Tanaka H, Lee H, Azekawa S, Otake S, Fukushima T, Morita A, Watase M, Sakurai K, Kusumoto T, Asakura T, Masaki K, Kamata H, Ishii M, Hasegawa N, Harada N, Ueda T, Ueda S, Ishiguro T, Arimura K, Saito F, Yoshiyama T, Nakano Y, Mutoh Y, Suzuki Y, Edahiro R, Murakami K, Sato Y, Okada Y, Koike R, Kitagawa Y, Tokunaga K, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K. Nakagawara K, et al. Among authors: fukunaga k. Respir Res. 2022 Nov 15;23(1):315. doi: 10.1186/s12931-022-02222-3. Respir Res. 2022. PMID: 36380316 Free PMC article.
Thymoma-associated T-cell immunodeficiency after radiotherapy: A case report.
Nakagawara K, Chubachi S, Azekawa S, Otake S, Saito A, Okada M, Lee K, Masaki K, Koike N, Kamata H, Kawada I, Suzuki S, Ishii M, Fukunaga K. Nakagawara K, et al. Among authors: fukunaga k. Respir Med Case Rep. 2021 Apr 2;33:101408. doi: 10.1016/j.rmcr.2021.101408. eCollection 2021. Respir Med Case Rep. 2021. PMID: 34401256 Free PMC article.
Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics.
Otake S, Chubachi S, Namkoong H, Nakagawara K, Tanaka H, Lee H, Morita A, Fukushima T, Watase M, Kusumoto T, Masaki K, Kamata H, Ishii M, Hasegawa N, Harada N, Ueda T, Ueda S, Ishiguro T, Arimura K, Saito F, Yoshiyama T, Nakano Y, Mutoh Y, Suzuki Y, Murakami K, Okada Y, Koike R, Kitagawa Y, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K; Japan COVID-19 Task Force. Otake S, et al. Among authors: fukunaga k. BMC Infect Dis. 2022 Sep 14;22(1):735. doi: 10.1186/s12879-022-07701-y. BMC Infect Dis. 2022. PMID: 36104674 Free PMC article.
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study.
Matsubara Y, Kiyohara H, Mikami Y, Nanki K, Namkoong H, Chubachi S, Tanaka H, Azekawa S, Sugimoto S, Yoshimatsu Y, Sujino T, Takabayashi K, Hosoe N, Sato T, Ishii M, Hasegawa N, Okada Y, Koike R, Kitagawa Y, Kimura A, Imoto S, Miyano S, Ogawa S, Fukunaga K, Kanai T; Japan COVID-19 Task Force. Matsubara Y, et al. Among authors: fukunaga k. J Gastroenterol. 2024 Mar;59(3):195-208. doi: 10.1007/s00535-023-02071-x. Epub 2024 Jan 25. J Gastroenterol. 2024. PMID: 38270615
The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
Miyazaki M, Nakamura H, Takahashi S, Chubachi S, Sasaki M, Haraguchi M, Terai H, Ishii M, Fukunaga K, Tasaka S, Soejima K, Asano K, Betsuyaku T; Keio COPD Comorbidity Research (K-CCR) group. Miyazaki M, et al. Among authors: fukunaga k. Int J Chron Obstruct Pulmon Dis. 2015 Jun 4;10:1053-9. doi: 10.2147/COPD.S79864. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 26082629 Free PMC article.
1,367 results